La ventaja estratégica de las empresas biofarmacéuticas de alta tecnología, depende cada día más de su capacidad para acumular activos intangibles mediante un proceso cuidadosamente planificado y ejecutado de creación de competencias laborales.
Yanela Cadalzo-Díaz +3 more
doaj
[Technological and market analysis of the hemodialysis membranes segment in Brazil based on federal public procurement data]. [PDF]
Barcelos GFJ +3 more
europepmc +1 more source
[Research and commercial exploitation in bacteriology: Silvio Dessy and the Argentine Biological Institute between 1908 and 1947]. [PDF]
Rojas NF.
europepmc +1 more source
[Peripheral promises: expectations, coalitions and covid-19 vaccines in Argentina]. [PDF]
Sanmartin MC, Bortz G.
europepmc +1 more source
[Technological healthcare management arrangements: challenges for contemporary hospitals]. [PDF]
Chioro A, Correia T.
europepmc +1 more source
Pressure on bony prominences in the dorsal, lateral, and ventral decubitus: a clinical trial. [PDF]
Borges EL +4 more
europepmc +1 more source
Technology transfer for COVID-19 vaccine in the Institute of Technology in Immunobiologicals (Bio-Manguinhos), Oswaldo Cruz Foundation. [PDF]
Rosenberg VZ, Antunes AMS.
europepmc +1 more source
[Home Respiratory Therapies: SEPAR Technical Document for Institutional Decision Support]. [PDF]
Marcos PJ +4 more
europepmc +1 more source
[Organizational culture: The influence of leadership in improving institutional health processes]. [PDF]
Legorreta-Rojas M, Trejo-Amador U.
europepmc +1 more source
Educational technology to empower patients as participants in their care. [PDF]
Ramos RDS +6 more
europepmc +1 more source

